Cover Image
市場調查報告書

高度創傷護理的全球市場

Wound Care Markets (Skin Ulcer Treatment, Burn Treatment, Hydrocolloids, Adhesives, Pressure Relief, Silver, Regenerative Products, Trauma Care, NPWT, Dressings, Tapes, Debridement, Collagen, Staples, Sutures and Other Devices)

出版商 Kalorama Information 商品編碼 204409
出版日期 內容資訊 英文 320 Pages
訂單完成後即時交付
價格
本報告書已不再販售
Back to Top
高度創傷護理的全球市場 Wound Care Markets (Skin Ulcer Treatment, Burn Treatment, Hydrocolloids, Adhesives, Pressure Relief, Silver, Regenerative Products, Trauma Care, NPWT, Dressings, Tapes, Debridement, Collagen, Staples, Sutures and Other Devices)
出版日期: 2016年12月15日 內容資訊: 英文 320 Pages

本報告已在2017年05月19日停止出版

簡介

2016年的全球高度創傷護理的市場,以製造商銷售額為準收益規模推算為209億8070萬美元。

本報告提供全球高度創傷護理的市場調查,提供您創傷種類與概要,創傷護理產品種類與概要,創傷區分·治療方法及產品區分·各地區的市場規模變化與預測,主要國家的醫療制度,產業主要的發展情形,競爭環境,並彙整主要企業的簡介等資訊。

第1章 摘要整理

第2章 簡介·概要

  • 皮膚功能
  • 正常外皮
  • 表皮
  • 真皮
  • 皮下組織
  • 老化對外皮系統的影響
  • 創傷治療的種類
  • 創傷治療的流程
  • 傷口癒合不良
  • 創傷治療的併發症

第3章 創傷的主要類型

  • 皮膚損傷
  • 壓力造成的損傷或褥瘡性潰瘍
  • 糖尿病性潰瘍或神經病變性潰瘍
  • 動脈性潰瘍
  • 靜脈潰瘍
  • 燒燙傷
  • 燙傷
  • 化學性損傷
  • 電力造成的損傷
  • 深層分類
  • 手術疤痕
  • 外傷

第4章 創傷護理產品

  • 抗感染劑
  • 壓迫·複合敷料
  • 縫合材料
  • 縫合器·釘針
  • 組織黏合劑·密封膠·黏劑
  • 血管閉合設備
  • 黏合帶·膠帶
  • 乾燥敷料材
  • 清洗材
  • 清創手術
  • 藻酸鹽
  • 親水膠體
  • 水凝膠
  • 薄膜
  • 海綿敷料材
  • 生物邏輯敷料
  • 細胞·組織型產品
  • 羊膜
  • 生長因子
  • 膠原蛋白
  • 傷口負壓治療等

第5章 全球皮膚潰瘍治療市場分析

  • 概要
  • 抗感染藥
  • 皮膚潰瘍管理
  • 濕敷材料
  • 傷口負壓治療
  • 生物敷料
  • 壓力解放設備
  • 其他治療方法
  • 競爭摘要
  • 整體市場分析
  • 整體市場分析:各種類
  • 整體市場分析:各地區
  • 競爭分析

第6章 全球燒燙傷治療市場分析

  • 抗感染藥
  • 燒燙傷管理
  • 濕敷料
  • 生物敷料
  • 壓力解放設備
  • 其他治療方法
  • 競爭摘要
  • 整體市場分析
  • 整體市場分析:各種類
  • 整體市場分析:各地區
  • 競爭分析

第7章 全球術疤痕·外傷治療市場分析

  • 傷口縫合
  • 抗感染藥
  • 術疤痕·外傷管理
  • 濕敷材料
  • 生物敷料
  • 其他治療方法
  • 整體市場分析
  • 整體市場分析:各種類
  • 整體市場分析:各地區
  • 競爭分析

第8章 整體市場規模與預測·競爭分析

  • 市場摘要
  • 整體市場:各種類
  • 各類型市場
  • 各用途市場
  • 各地區市場
  • 競爭市場摘要

第9章 產業的發展

  • 敷料的積極利用
  • 全球人口動態
  • 高齡化的影響
  • 全球創傷患病人數
  • 競標契約
  • 法律規章上的課題
  • 醫療制度·給付制度:各國
  • 創傷護理的各種技術
  • 已通過核准產品
  • 開發中的產品
  • 醫療設備稅
  • 依證的創傷護理
  • 成本相關考察
  • 居家護理
  • 疤痕治療
  • 間質幹細胞的利用
  • 利用蜂蜜的治癒
  • 遠程醫療 (遠端照護) 和傷口護理
  • 維他命D
  • 傷口護理用應用程式
  • 肥胖和創傷治療等

第10章 總論

第11章 企業簡介

圖表

目錄
Product Code: KLI15193105

The worldwide wound care market reached revenues of $20,980.7 million in 2016 based on sales at the manufacturers' level. The market is varied in terms of both product offerings and product maturity. Several of the products within the worldwide wound care market are mature such as anti-infectives and pressure relief devices, while others such as biological dressings and negative pressure wound therapy are in the growth stages of development. Thus, some products within the market are slowing in growth rates while others are driving growth.

Kalorama Information's Advanced Wound Care Markets Worldwide Provides useful information to business planners including market size estimates for various segments, forecasts, trend analysis, competitive analysis, corporate profiles, market share and other information. The worldwide wound care market is a technologically enriched environment dedicated to advancing wound care therapies. Overall, the industry is showing renewed signs of growth as the demand for products remains strong. Wound care is a balancing act due to the aging population and co-morbidity of diseases such as diabetes, cardiovascular disease, obesity and other diseases that present an ever-present challenge to wound care practitioners and manufacturers alike.

Skin Ulcers:

Skin ulcer wound treatment is a complex, intricate series of events influenced by internal and external conditions. Factors that influence the events of the wound-healing cascade are determined by deficiencies and comorbidities of the patient in addition to the environment of the wound. Treatments for skin ulcer wounds vary according to the type of wound and the individual needs of the wound but include the following categories:

  • Anti-infectives
  • Skin Ulcer Wound Management
  • Moist Dressings
  • Negative Pressure Wound Therapy
  • Biological Dressings
  • Pressure Relief Devices
  • Miscellaneous Skin Ulcer Treatments

Burn Treatment:

Burn wound management consists of measures to limit bacterial infection in the wound and on adjacent tissue. The burn has left the body susceptible to serious infection. The first line of defense, the skin, has been destroyed by the burn injury. At first, burn wounds are sterile because of the heat that caused the burn, but bacterial flora soon re-establishes colonies on the burned skin or Escher. The medium is favorable for pathogenic growth because of the necrotic tissue and warm environment that exist within the burn wound dressing. Benign microorganisms normally found on the skin, in the gastrointestinal tract, and in the pulmonary system become lethal as they colonize the burn wound and invasive sepsis occurs. Burn recovery is long an with complications the rule rather than the exception. The report covers the following products in burn wound management:

  • Burn Anti-infectives
  • Burn Injury Management
  • Burn Moist Dressings
  • Burn Biological Dressings
  • Burn Pressure Relief Devices
  • Miscellaneous Burn Treatments

Surgical Trauma and wound treatment influenced by internal and external conditions. Factors that influence the events of the wound-healing cascade are determined by deficiencies and comorbidities of the patient in addition to the environment of the wound. Treatments for surgical and traumas wounds vary according to the type of wound and the individual needs of the wound but include the following categories:

  • Wound closure
  • Wound management
  • Moist dressings
  • Biological dressings
  • Miscellaneous treatments

Given that we are experiencing a worldwide aging of the population, these co-morbid diseases will continue to influence wound care challenges. All of this is influenced by and dependent on reimbursement coverage since most patients are over 65 years of age. onventional, mature products continue to generate the majority of sales; however, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. The aging of the population and continued advances in biotechnology drive the wound care industry. As a result of the growing population of the elderly, healthcare systems are challenged to treat rising incidences of complex diseases and conditions. Patients are being moved through the hospital faster putting more pressure on caregivers across all care settings and increasing the need for more sophisticated means to care for these patients. Enjoying market success depends on several factors. Manufacturers must develop a formidable strategy, which involves matching internal capabilities with external opportunities. By choosing to implement such strategies, providers are able to achieve high levels of clinical success while controlling use and costs. Manufacturers are continuing to create well-rounded and advanced products to provide a wider variety of choices.

Among the companies profiled in this report are the following:

  • 3M Health Care
  • ABL Medical, LLC
  • Acelity L.P. Inc.
  • Acell, Inc
  • Alliqua Biomedical, Inc.
  • Amniox Medical
  • Angelini Pharma, Inc
  • Argentum Medical, LLC
  • ArjoHuntleigh
  • Arobella Medical, LLC
  • Baxter Bioscience
  • B. Braun/Aesculap, Inc.
  • BSN Medical, Inc.
  • Cardinal Health, Inc
  • Coloplast A/S
  • ConvaTec, Inc.
  • Crawford Healthcare Ltd.
  • Cyrolife, Inc.
  • Curaline, Inc.
  • Derma Sciences
  • DeRoyal Industries
  • EHOB, Inc
  • Ethicon, Inc.
  • GlaxoSmithKline, Plc.
  • Hartmann USA, Inc
  • Hill-Rom Company, Inc.
  • Hollister Wound Care, LLC
  • Integra Life Sciences
  • Johnson & Johnson
  • Lifebond Ltd.
  • Lohmann and Rauscher GmbH & Co. KG
  • Marine Polymer Technologies, Inc.
  • Medline Industries, Inc
  • Medtronic Plc
  • MiMedx Group, Inc
  • MoInlycke Healthcare, LLC
  • MPM Medical, Inc.
  • Oculus Innovative Sciences, Inc
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.
  • Pfizer, Inc.
  • Smith & Nephew, Plc
  • Soluble Systems, LLC
  • Southwest Technologies
  • SteadMed Medical
  • Stryker Corp

Another area driving growth is the negative pressure wound therapy. The market is expected to exhibit an overall steady growth rate due to the increasing elderly population, rising rate of disease such as diabetes and obesity, availability of new therapeutic techniques, and the recent focus on wound care products and prevention.

There have been many research advancements in the last decade. However, recently hese advancements are taking place on a daily basis with the most significant changes in the past 30 years. New developments are providing the health care arena of today with some truly sophisticated, highly effective wound care treatments. With respect to wound dressings, the focus has been more on their categories rather than on their functions. Recent discussions have surfaced in literature that take note of this situation. There is a decided move for a paradigm shift in decision making about dressings. The shift is described as the interactive and active use of dressing materials in the same way as drugs, with specific actions, interactions, contraindications, indications, and side effects.

The emerging generation of wound care products and technologies are well positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.

The worldwide wound care market is based on total manufacturers' revenues. The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face-to-face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2016. Historical data are provided for each of the years 2014 through 2016, and forecast data are provided for each of the years 2016 through 2021. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2016 base year.

Q&A With Analyst, Advanced Wound Care Markets

  • Q: What are some of the challenges facing the market?
  • A: There is significant market potential for advanced wound care products if barriers such as cost and ‘old school' attitudes can be overcome. Many physicians are reluctant to deviate away from the tried and true traditional wound care products. Education and familiarity with these new products coupled with demonstrated cost savings will propel the market forward
  • Q: What is driving wound care sales?
  • A: You reap what you sow in this business Growth will be driven by technologically advanced products and therapies that are more cost effective and clinically efficient. On-going research and development of products is essential for future development of the industry. The goal is still to provide products that improve efficacy and control costs.

Other than that there are traditional factors. Aging of the population will have several varied effects on the healthcare industry as a whole, with specific implications for wound care. First, aging of the population will bring increased prevalence of chronic diseases-such as asthma, chronic obstructive pulmonary disorder (COPD), congestive heart failure (CHF), coronary heart disease (CHD), diabetes and osteoarthritis-which are more prevalent among the elderly. This will increase the need for wound care among the elderly population.

In addition, the elderly population itself is changing.

The global population above age 65 is expected to grow by 279% between 2000 and 2050. This growth is showing the fastest increase from 2040 through 2050 showing a progressive rise in the aging population.

In comparison, the total global population is expected to increase by 54% between 2000 and 2050 (6.1 billion to 9.4 billion).

  • Q: What trends uncovered in the research?
  • A: Pressure relief is an area of great demand but great challenge. Presure injuries are common in the old population. CMS is making a decision on pressure injuries in heatlhcare setting that they will not reimburse secondary visits for relief treatments. . The Healthcare Cost and Utilization Project released information involving the treatment of pressure injuries in 2006. In 2006, there were 503,300 hospital stays during which pressure injuries were noted- a 78.9% increase from 1993 when there were about 281,300 hospital stays related to pressure injuries. During the same period, however, the total number of hospitalizations increased by only 15%.

Apps are another interesting. There are apps available everywhere for most everything and wound care is no exception. MoInlycke Healthcare launched an iPhone application for its Avance Negative Pressure Wound Therapy System. The app includes dressing application guides for the Avance system, access to customer services and details for ordering. The app can be downloaded on an iPhone, iPad or iPod Touch currently and the company is working on adding formats for other smartphones. Other companies are introducing their versions of apps for products in their line. It is expected that this application of technology will continue to grow in the future and become more common place in the industry.

Some examples of apps include the MOWA- Mobile Wound Analyzer - which is an application for advanced management of pressure injuries, diabetes and vascular disease. It is sophisticated and practical software for analyze images of ulcers and may also be useful as a reference manual and guide for post -visual evaluation. It is target to health professionals who heal wounds or want to learn how to heal wounds.

We are likely to see more apps in the future that are more intuitive and incorporate more assessment information.

  • Q: How is the Regulatory environment for wound care?
  • A: Changes are abundant. Over the past few years, there have been many regulatory changes and issues involving wound care. Some of the more notable changes that have directly impacted the market include:
  • Sunshine Physician Payment which requires medical manufacturers to report payments or other transfers of value to covered recipients i.e. physicians, hospitals etc. Start date for the tracking was August 1, 2013 and it was to be reported to CMS by March 31, 2014.
  • Medical Device Tax is a tax on the sale of certain medical devices by the manufacturer or importer of the device. The tax applies to sales after December 2012 and is 2.3 percent of the sale price of the taxable items. This encompasses most of the products in the wound care arena. In January 2016, there was a moratorium on the medical device tax until 2017. With a new administration in office, it remains to be seen if the medical device tax will be repealed or reinstated in 2017
  • Unique Device Identifier (UDI) which is a unique numeric or alphanumeric code that includes a device identifier, batch number, serial number and expiration date.

Table of Contents

1: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Trends Affecting the Market
  • Competitive Outlook

2: Introduction and Overview

  • Functions of the Skin
  • Normal Integument
  • Epidermis
  • Dermis
  • Subcutaneous Tissue
  • Effects of Aging on the Integumentary System
  • Types of Wound Healing
  • Wound Healing Process
  • Delays of Wound Healing
  • Complications of Wound Healing

3: Main Types of Wounds

  • Skin Injuries
  • Pressure Injuries or Decubitus Ulcers
  • Diabetic Ulcers or Neuropathic Ulcers
  • Arterial Ulcers
  • Venous Ulcers
  • Burns
  • Thermal Injury
  • Chemical Injury
  • Electrical Injury
  • Depth Classification
  • Surgical Wounds
  • Trauma Wounds

4: Wound Care Treatment Products

  • Anti-Infectives
  • Industry Innovations
  • Compression and Composite Dressings
  • Industry Innovations
  • Sutures
  • Absorbable
  • Nonabsorbable
  • Staplers and Staples
  • Tissue Adhesives, Sealants and Glues
  • Fibrin-based
  • Collagen-based
  • Vascular Closing Devices
  • Synthetic Adhesives/Glues
  • Industry Innovations
  • Adhesive Strips and Tapes
  • Dry Dressings
  • Industry Innovations
  • Cleansing
  • Debridement
  • Industry Innovations
  • Alginates
  • Industry Innovations
  • Hydrocolloids
  • Industry Innovations
  • Hydrogels
  • Industry Innovations
  • Films
  • Industry Innovations
  • Foam Dressings
  • Industry Innovations
  • Biological Dressings
  • Cellular/Tissue-Based Products
  • Amniotic Membrane
  • Growth Factors
  • Industry Innovations
  • Collagen
  • Industry Innovations
  • Negative Pressure Wound Therapy
  • Industry Innovations
  • Pressure Relief
  • Industry Innovations
  • Miscellaneous
  • Electrical Stimulation
  • Ultraviolet
  • Oxygen and Hyperbaric Oxygen
  • Whirlpool Therapy
  • Electromagnetic Therapy Device
  • Ultrasound
  • Low Intensity Laser Therapy
  • Other Therapies

5: Worldwide Skin Ulcer Wound Treatment Market Analysis

  • Overview
  • Anti-Infectives
  • Competitive Summary
  • Skin Ulcer Management
  • Competitive Summary
  • Moist Dressings
  • Competitive Summary
  • Negative Pressure Wound Therapy
  • Competitive Summary
  • Biological Dressings
  • Competitive Summary
  • Pressure Relief Devices
  • Competitive Summary
  • Miscellaneous Skin Ulcer Treatments
  • Competitive Summary
  • Total Worldwide Skin Ulcer Treatment Market Analysis
  • Total Worldwide Skin Ulcer Treatment Market by Segment
  • Total Worldwide Skin Ulcer Treatment Market by Region
  • Total Worldwide Skin Ulcer Treatment Market Competitive Analysis

6: Worldwide Burn Wound Treatment Market Analysis

  • Anti-Infectives
  • Competitive Summary
  • Burn Injury Management
  • Competitive Summary
  • Moist Dressings
  • Competitive Summary
  • Biological Dressings
  • Competitive Summary
  • Pressure Relief Devices
  • Competitive Summary
  • Miscellaneous Burn Treatments
  • Competitive Summary
  • Total Worldwide Burn Treatment Market Analysis
  • Total Worldwide Burn Treatment Market by Segment
  • Total Worldwide Burn Treatment Market by Region
  • Total Worldwide Burn Treatment Market Competitive Analysis

7: Worldwide Surgical and Trauma Wound Treatment Analysis

  • Wound Closure
  • Anti-Infectives
  • Surgical and Trauma Wound Management
  • Moist Dressings
  • Biological Dressings
  • Miscellaneous Surgical Wound and Trauma Treatments
  • Total Worldwide Surgical and Trauma Wound Treatment Market Analysis
  • Total Worldwide Surgical and Trauma Wound Treatment Market by Segment ......
  • Total Worldwide Surgical and Trauma Wound Treatment Market by Region
  • Total Worldwide Surgical and Trauma Wound Treatment Market Competitive Analysis

8: Total Worldwide Wound Care Market Size, Forecast and Competitive Analysis

  • Market Summary
  • Total Market by Segment
  • Market by Type
  • Market by Application
  • Market by Region
  • Competitive Market Summary

9: Industry Developments

  • Interactive and Active Use of Dressings
  • World Demographics
  • IMPACT OF AGING POPULATIONS
  • Worldwide Prevalence of Wounds
  • Competitive Bidding Contracts
  • Regulatory Issues
  • Healthcare System and Reimbursement by Country
  • United States
  • United Kingdom
  • Germany
  • Spain
  • Italy
  • France
  • Japan
  • Emerging Markets
  • Wound Care Technologies
  • Approved Products
  • Products in Development
  • Electronic Medical Records
  • Medical Device Tax
  • Non-Payment Events
  • Evidence-Based Wound Care
  • Wound Closure Cost Considerations
  • Home Care
  • Scar Treatment
  • Mesenchmyal Stem Cell Use in Wound Care
  • Honey Treatment
  • Telemedicine and Wound Care
  • Vitamin D
  • Apps for Wound Care
  • Obesity and Wound Healing
  • Silver Toxicity
  • Surgical Infection
  • Wound Care Clinics

10: Conclusions

  • Conclusion 1
  • Conclusion 2
  • Conclusion 3
  • Conclusion 4
  • Conclusion 5
  • Conclusion 6
  • Conclusion 7
  • Conclusion 8
  • Conclusion 9
  • Conclusion 10
  • Conclusion 11
  • Conclusion 12
  • Conclusion 13
  • Conclusion 14
  • 11: Company Profiles
  • Overview
  • 3M Health Care
  • Company Overview
  • Company Financials
  • ABL Medical, LLC
  • Company Overview
  • Acelity L
  • Company Overview
  • Company Financials
  • Acell, Inc
  • Company Overview
  • Alliqua Biomedical, Inc
  • Company Overview
  • Company Financials
  • Amniox Medical
  • Company Overview
  • Angelini Pharma, Inc
  • Company Overview
  • Argentum Medical, LLC
  • Company Overview
  • ArjoHuntleigh
  • Company Overview
  • Company Financials
  • Arobella Medical, LLC
  • Company Overview
  • Baxter Bioscience
  • Company Overview
  • Company Financials
  • B. Braun/Aesculap, Inc
  • Company Overview
  • BSN Medical, Inc
  • Company Overview
  • Cardinal Health, Inc
  • Company Overview
  • Company Financials
  • Coloplast A/S
  • Company Overview
  • Company Financials
  • ConvaTec, Inc
  • Company Overview
  • Company Financials
  • Crawford Healthcare Ltd
  • Company Overview
  • Cyrolife, Inc
  • Company Overview
  • Company Financials
  • Curaline, Inc
  • Company Overview
  • Derma Sciences
  • Company Overview
  • Company Financials
  • DeRoyal Industries
  • Company Overview
  • EHOB, Inc
  • Company Overview
  • Ethicon, Inc
  • Company Overview
  • Company Financials
  • GlaxoSmithKline, Plc
  • Advanced Wound Care Markets Worldwide
  • Company Overview
  • Company Financials
  • Hartmann USA, Inc
  • Company Overview
  • Company Financials
  • Hill-Rom Company, Inc
  • Company Overview
  • Company Financials
  • Hollister Wound Care, LLC
  • Company Overview
  • Integra Life Sciences
  • Company Overview
  • Company Financials
  • Johnson & Johnson
  • Company Overview
  • Company Financials
  • Lifebond Ltd
  • Company Overview
  • Lohmann and Rauscher GmbH & Co
  • Company Overview
  • Marine Polymer Technologies, Inc
  • Company Overview
  • Medline Industries, Inc
  • Company Overview
  • Medtronic Plc
  • Company Overview
  • Company Financials
  • MiMedx Group, Inc
  • Advanced Wound Care Markets Worldwide
  • Company Overview
  • Company Financials
  • MoInlycke Healthcare, LLC
  • Company Overview
  • Company Financials
  • MPM Medical, Inc
  • Company Overview
  • Oculus Innovative Sciences, Inc
  • Company Overview
  • Company Financials
  • Organogenesis, Inc
  • Company Overview
  • Osiris Therapeutics, Inc
  • Company Overview
  • Company Financials
  • Pfizer, Inc
  • Company Overview
  • Company Financials
  • Smith & Nephew, Plc
  • Company Overview
  • Company Financials
  • Soluble Systems, LLC
  • Company Overview
  • Southwest Technologies
  • Company Overview
  • SteadMed Medical
  • Company Overview
  • Stryker Corp
  • Company Overview
  • Company Financials

List of Exhibits

1: Executive Summary

  • Table 1-1: Total Worldwide Wound Care Market Revenues, 2014-2021 <>3: Main Types of Wounds
  • Table 3-1: Common Sites for Pressure Injury Development
  • Table 3-2: Stages of Pressure Injuries

4: Wound Care Treatment Products

  • Table 4-1: Selected Topical Brand Name Anti-Infectives Currently Available(Product, Active Ingredient, Manufacturer)
  • Table 4-2: Selected Compression and Composite Dressings and Bandages Currentlyon the Market
  • Table 4-3: Selected Absorbable and Knotless Sutures by Manufacturers andProducts
  • Table 4-4: Selected Nonabsorbable Sutures by Manufacturers and Products
  • Table 4-5: Selected Staplers and Staples Manufacturers and Products
  • Table 4-6: Selected Tissue Adhesives, Sealants, and Glues Manufacturers andProducts
  • Table 4-7: Selected Adhesive Strips and Tapes Currently on the Market
  • Table 4-8: Selected Dry Dressing (Woven and Nonwoven) Currently on theMarket
  • Table 4-9: Toxicity Index for Selected Wound Cleansers
  • Table 4-10: Selected Cleansing Agents Currently on the Market
  • Table 4-11: Selected Debridement Agents
  • Table 4-12: Selected Alginate Products Currently on the Market
  • Table 4-13: Selected Hydrocolloid Products Currently on the Market
  • Table 4-14: Selected Hydrogel Products Currently on the Market
  • Table 4-15: Selected Films and Composites Currently on the Market
  • Table 4-16: Selected Foam Manufacturers and Products
  • Table 4-17: Selected Skin Substitute and Regenerative Products Currently onthe Market
  • Table 4-18: Selected Collagen Products Currently on the Market
  • Table 4-19: Selected Negative Pressure Wound Therapy Products Currently onthe Market
  • Table 4-20: Selected Pressure Relief Equipment Currently Available
  • Table 4-21: Selected Miscellaneous Wound Treatment Manufacturers andProducts

5: Worldwide Skin Ulcer Wound Treatment Market Analysis

  • Table 5-1: Market for Anti-Infectives in the Treatment of Skin Ulcers,2014-2021
  • Table 5-2: Anti-Infectives for Skin Ulcers Market Competitor Summary,Revenues and Market Share by Supplier (Est), 2016
  • Table 5-3: Skin Ulcer Management Market Segment Summary Revenues bySegment, 2014-2021, Manufacturer's Revenues
  • Table 5-4: Skin Ulcer Management: Revenues and Market Share by LeadingSupplier (Est), 2016
  • Table 5-5: Skin Ulcers: Alginates, Hydrocoloids, Hydrogels, Films, Foams,2014-2021
  • Table 5-6: Moist Dressings: Revenues and Market Share by Leading Supplier(Est), 2016
  • Table 5-7: Market for Negative Pressure Wound Therapy in Skin Ulcer Treatment,2014-2021
  • Table 5-8: Negative Pressure Wound Therapy: Revenues and Market Share byLeading Supplier (Est), 2016
  • Table 5-9: Biological Dressings Market Segment Summary Revenues bySegment (Skin Substitutes and Regenerative Tissues, Collagen, GrowthFactors, Others), 2014-2021
  • Table 5-10: Biological Dressings: Revenues and Market Share by LeadingSupplier (Est), 2016
  • Table 5-11: The Market for Pressure Relief Devices in Skin Ulcers, 2014-2021 ....
  • Table 5-12: Pressure Relief Devices: Revenues and Market Share by LeadingSupplier (Est), 2016
  • Table 5-13: The Market for Miscellaneous Skin Ulcers Treatment, 2014-2021 ......
  • Table 5-14: Miscellaneous Skin Ulcer Treatment Market Competitor Summary,Revenues and Market Share by Leading Supplier (Est), 2016
  • Table 5-15: Skin Ulcers Revenue Growth Rate by Segment, 2014-2021,Manufacturer Revenue (Anti-infectives, Skin Ulcer Management, Moist Dressings,Negative Pressure Wound Therapy, Biological Dressings, Pressure ReliefDevices, Miscellaneous Treatments)
  • Table 5-16: Skin Ulcers Share by Segment, 2014-2021, Share of Total Market(%) (Anti-infectives, Skin Ulcer Management, Moist Dressings, NPWT, BiologicalDressings, Pressure Relief, Misc Treatments)
  • Figure 5-1: Skin Ulcers Market Share by Type, 2016 (%) (Anti-infective, UlcerManagement, Moist, NPWT, Biologics, Pressure Relief, Misc)
  • Figure 5-2: Skin Ulcer Market Share by Type, 2021 (%) (Anti-infective, UlcerManagement, Moist, NPWT, Biologics, Pressure Relief, Misc)
  • Figure 5-3: Worldwide Skin Ulcer Wound Care Revenues by Region, (US, Europe, Japan, ROW)
  • Table 5-17: Revenues and Share of Total Skin Ulcer Market by Leading Supplier(Est), 2016
  • Figure 5-4: Skin Ulcer Market Share by Leading Supplier, 2016 (%)

6: Worldwide Burn Wound Treatment Market Analysis

  • Table 6-1: The Worldwide Market for Anti-Infectives for Burns, 2014-2021
  • Table 6-2: Anti-Infectives for Burns Market Competitor Summary, Revenues and
  • Market Share by Supplier (Est), 2016
  • Table 6-3: World Market for Burn Management Products, Revenues by Segment(Cleansing, Debridement, Silver Dressings), 2014-2021, Manufacture Revenues ...
  • Table 6-4: Burn Injury Management Market Competitor Summary (Est), 2016,Revenues and Market Share by Supplier
  • Table 6-5: World Market for Moist Dressing for Burns, Revenues by Segment(Alginates, Hydrocolloids, Hyrogels, Films, Foams), 2014-2021
  • Table 6-6: Burns: Moist Dressing Market Competitor Summary, Revenues andMarket Share by Supplier, 2016
  • Table 6-7: World Market for Biological Dressings for Burns, Revenues bySegment (Skin Substitutes and Regenerative Products, Collagens), 2014-2021,Manufacturer Revenues
  • Table 6-8: Biological Dressings for Burns Market Competitor Summary,Revenues and Market Share by Supplier (Est), 2016
  • Table 6-9 Burn Pressure Relief Market Segment Summary, ManufacturerRevenues, 2014-2021:
  • Table 6-10: Burn Pressure Relief Devices Market Competitor Summary, Revenuesand Market Share by Supplier (Est), 2016
  • Table 6-11: Miscellaneous Burn Treatment Market Segment Summary,Manufacturer Revenues, 2014-2021
  • Table 6-12: Miscellaneous Burn Treatment Market Competitor Summary,Revenues and Market Share by Supplier, (Est) 2016
  • Table 6-13: Revenues by Segment (Anti-Infectives, Burn Injury Management,Moist Dressings, Biological Dressings, Pressure Relief Devices,Miscellaneous Burn Treatments, 2014-2021, Manufacturer Revenue
  • Table 6-14: Revenues by Segment (Anti-Infectives, Burn Injury Management,Moist Dressings, Biological Dressings, Pressure Relief Devices,Miscellaneous Burn Treatments), Share of Total Market, 2014-2021
  • Figure 6-1: Burn Market Share by Type, 2016 (Anti-infective, Ulcer Management,Moist, NPWT, Biologics, Pressure Relief, Misc)
  • Figure 6-2: Burn Market Share by Type, 2021 (Anti-infective, Ulcer Management,Moist, NPWT, Biologics, Pressure Relief, Misc)
  • Figure 6-3: Burn Care Revenues by Region, 2016 (US, Europe, Japan, ROW) ......
  • Table 6-15: World Burn Market Competitor Summary, Revenues and MarketShare by Supplier (Est), 2016
  • Figure 6-4: Burn Market Share by Competitor, 2016

7: Worldwide Surgical and Trauma Wound Treatment Analysis

  • Table 7-1: World Market for Wound Closure Products by Type (Sutures, Staplersand Staples, Tissue Adhesives, Sealants, Glues), 2014-2021, ManufacturerRevenues
  • Table 7-2: Surgical and Trauma Wound Closure Market Competitor Summary,Revenues and Market Share by Supplier (Est), 2016
  • Table 7-3: Market for Anti-Infectives for Surgical and Trauma Wounds,2014-2021
  • Table 7-4: Anti-Infectives for Surgical and Trauma Wounds Market CompetitorSummary, Revenues and Market Share by Supplier (Est), 2016
  • Table 7-5: World Market for Wound Management Products for Surgical and TraumaWounds Revenues by Segment (Cleansing, Debridement, Tapes, Dry Dressings),2014-2021, Manufacturer Revenues
  • Table 7-6: Wound Management for Surgical and Trauma Wounds MarketCompetitor Summary, Revenues and Market Share by Supplier (Est), 2016
  • Table 7-7: World Market for Moist Dressing for Surgical and Trauma Wounds,Revenues by Segment (Alginates, Hydrocolloids, Hydrogels, Films, Foams),2014-2021
  • Table 7-8: Moist Dressing for Surgical and Trauma Wounds Market CompetitorSummary, Revenues and Market Share by Supplier (Est), 2016
  • Table 7-9: World Market for Biological Dressings for Surgical and TraumaWounds, Revenues by Segment (Skin Substitutes and Regenerative Products,Collagens), 2014-2021, Manufacturer Revenues
  • Table 7-10: Biological Dressing for Surgical and Trauma Wounds MarketCompetitor Summary, Revenues and Market Share by Supplier (Est), 2016
  • Table 7-11: Miscellaneous Surgical and Trauma Wound Treatment MarketSegment Summary, Manufacturer Revenues, 2014-2021
  • Table 7-12: Miscellaneous Surgical and Trauma Treatment Market CompetitorSummary, Revenues and Market Share by Supplier, 2016
  • Table 7-13: World Surgical and Trauma Wound Product Revenues by Segment,2014-2021, Manufacturer Revenues (Wound Closure, Anti-Infectives, WoundManagement, Moist Dressings, Biological Dressings, Misc Treatments)
  • Table 7-14: Surgical and Trauma Wound Care Share by Segment, 2014-2021, Shareof Total Market (%) (Wound Closure, Anti-Infectives, Wound Management, MoistDressings, Biological Dressings, Miscellaneous Treatment)
  • Figure 7-1: Surgical and Trauma Wound Care Market Share by Segment, (%) (Wound Closure, Anti-infectives, Wound Management, Moist, Biological,Misc)
  • Figure 7-2: Surgical and Trauma Wound Care Market Share by Segment, 2021 (%)(Wound Closure, Anti-infectives, Wound Management, Moist, Biological, Misc) .
  • Figure 7-3: Worldwide Surgical and Trauma Wound Care Revenues by Region,2016 (%) (US, Europe, Japan, ROW)
  • Table 7-15: World Surgical and Trauma Wound Care Market Competitor Summary,Revenues and Market Share by Supplier (Est), 2016
  • Figure 7-4: Trauma and Surgical Market Share by Competitor, 2016

8: Total Worldwide Wound Care Market Size, Forecast and Competitive Analysis

  • Table 8-1: Total Worldwide Wound Care Market Revenues, 2014-2021
  • Figure 8-1: The Worldwide Wound Care Market Revenues, 2014-2021
  • Table 8-2: Worldwide Wound Care Revenues by Segment (Surgical and Trauma,Skin Ulcers, Burns), 2016
  • Figure 8-2: Worldwide Wound Care by Segment (Surgical and Trauma, SkinUlcers, Burns), 2016 (%)
  • Table 8-3: Total Worldwide Wound Care Wound Closure Market Revenues,2014-2021
  • Figure 8-3: Worldwide Total Wound Closure Breakout, 2016 (%) (Sutures,Staples, Adhesives)
  • Table 8-4: Total Worldwide Anti-Infectives Wound Care Market Revenues,2014-2021
  • Table 8-5: Total Worldwide Wound Management Wound Care Market Revenues,2014-2021
  • Figure 8-4: Total Worldwide Wound Management Breakout, 2016 (%)(Cleansing, Debridement, Tapes, Bandages, Silver)
  • Table 8-6: Total Worldwide Moist Wound Care Market Revenues, 2014-2021 ......
  • Figure 8-5: Total Moist Wound Care Market Breakout, 2016 (%) (Alginates,Hydrocolloids, Hydrogels, Films, Foams)
  • Table 8-7: Total Worldwide NPWT Wound Care Market Revenues, 2014-2021 ....
  • Table 8-8: Total Worldwide Biological Wound Care Market Revenues,2014-2021
  • Figure 8-6: Total Biologic Dressings Breakout, 2016 (%) (Skin Subs &Regenerative, Collagen, Growth Factors, Others)
  • Table 8-9: Total Worldwide Pressure Relief Wound Care Market Revenues,2014-2021
  • Table 8-10: Total Worldwide Miscellaneous Wound Care Market Revenues,2014-2021
  • Table 8-11: Total Worldwide Market Segment Summary Revenues by Application(Wound Closure, Wound Management, Moist Dressings, Biological Dressings,Pressure Relief, NPWT, Miscellaneous), 2014-2021, Manufacture Revenues andGrowth Rate
  • Table 8-12: Total Worldwide Wound Care Market by Region and CountryBreakdown, 2016 (United States, Europe, Germany, France, Italy, United Kingdom,Others, Japan, Rest of World, Canada, China, India, Brazil, Others)
  • Figure 8-7: Worldwide Wound Care Revenues by Region, 2016 (US, Europe, Japan,ROW)
  • Figure 8-8: Worldwide Wound Care Revenues by Region, 2021 (US, Europe,Japan, ROW)
  • Table 8-13: Total Worldwide Wound Care Market Competitor Summary,Revenues and Market Share by Supplier (Est), 2016
  • Figure 8-9: Market Share by Leading Supplier, 2016

9: Industry Developments

  • Table 9-1: Global Population and Average Annual Change, 2005 - 2050
  • Table 9-2: Global Population Trends Age 65+, 2000-2050
  • Table 9-3: Global Prevalence of Wounds by Type (estimates), 2016 (Skin Ulcers,Pressure injuries, Venous statis ulcers, Diabetic ulcers, Burns, Outpatient burns,Hospitalized burns, Medically treated burns, Surgical Wounds, Traumatic Wounds)
  • Table 9-4: CMS Competitive Bidding Areas
  • Table 9-5: Selected Products in Development, 2016
  • Table 9-6: Clinical Trials Using MSC 2016

11: Company Profiles

  • Table 11-1: 3M Corporate Summary
  • Table 11-2: 3M Revenue (2013-2016)
  • Table 11-3: ABL Medical Corporate Summary
  • Table 11-4: Acelity Corporate Summary
  • Table 11-5: Acelity Revenue (2013-2016)
  • Table 11-6: Acell Corporate Summary
  • Table 11-7: Alliqua Biomedcial Corporate Summary
  • Table 11-8: Alliqua Biomedical Revenue (2013-2016)
  • Table 11-9: Amniox Medical Corporate Summary
  • Table 11-10: Angelini Pharma Corporate Summary
  • Table 11-11: Argentum Medical Summary
  • Table 11-12: ArjoHuntleigh Corporate Summary
  • Table 11-13: ArjoHuntleigh Revenue (2013-2016)
  • Table 11-14: Arobella Medical Corporate Summary
  • Table 11-15: Baxter Bioscience Corporate Summary
  • Table 11-16: Baxter Bioscience Revenue (2013-2016)
  • Table 11-17: B. Braun/Aesculap Corporate Summary
  • Table 11-18: BNS Medical Corporate Summary
  • Table 11-19: Cardinal Health Corporate Summary
  • Table 11-20: Cardinal Health Revenue (2013-2016)
  • Table 11-21: Coloplast A/S Corporate Summary
  • Table 11-22: Coloplast A/S Revenue (2013-2016)
  • Table 11-23: ConvaTec Corporate Summary
  • Table 11-24: ConvaTec Revenue (2013-2016)
  • Table 11-25: Crawford Healthcare Corporate Summary
  • Table 11-26: Cyrolife Corporate Summary
  • Table 11-27: CyroLife Revenue (2013-2016)
  • Table 11-28: Curaline Corporate Summary
  • Table 11-29: Derma Sciences Corporate Summary
  • Table 11-30: Derma Sciences Revenue (2013-2016)
  • Table 11-31: DeRoyal Industries Corporate Summary
  • Table 11-32: EHOB Corporate Summary
  • Table 11-33: Ethicon Corporate Summary
  • Table 11-34: Ethicon Revenue (2013-2016)
  • Table 11-35: GlaxoSmithKline Corporate Summary
  • Table 11-36: GSK Revenue (2013-2016)
  • Table 11-37: Hartmann USA Corporate Summary
  • Table 11-38: Hartmann USA Revenue (2013-2016)
  • Table 11-39: Hill-Rom Corporate Summary
  • Table 11-40: Hill-Rom Revenue (2013-2016)
  • Table 11-41: Hollister Wound Care Corporate Summary
  • Table 11-42: Integra Life Sciences Corporate Summary
  • Table 11-43: Integra Life Sciences Revenue (2013-2016)
  • Table 11-44: Johnson & Johnson Corporate Summary
  • Table 11-45: Johnson & Johnson Revenue (2013-2016)
  • Table 11-46: Lifebond Corporate Summary
  • Table 11-47: Lohmann and Rauscher Corporate Summary
  • Table 11-48: Marine Polymer Technologies Corporate Summary
  • Table 11-49: Medline Corporate Summary
  • Table 11-50: Medtronic Corporate Summary
  • Table 11-51: Medtronic Revenue (2013-2016)
  • Table 11-52: MiMiedx Corporate Summary
  • Table 11-53: MiMedx Revenue (2013-2016)
  • Table 11-54: MoInlycke Healthcare Corporate Summary
  • Table 11-55: MoInlycke Health Care Revenue (2013-2016)
  • Table 11-56: MPM Medical Corporate Summary
  • Table 11-57: Oculus Innovative Sciences Corporate Summary
  • Table 11-58: Oculus Revenue (2013-2016)
  • Table 11-59: Organogenesis Corporate Summary
  • Table 11-60: Osiris Therapeutics Corporate Summary
  • Table 11-61: Osiris Revenue (2013-2016)
  • Table 11-62: Pfizer Corporate Summary
  • Table 11-63: Pfizer Revenue (2013-2016)
  • Table 11-64: Smith & Nephew Corporate Summary
  • Table 11-65: Smith & Nephew Revenue (2013-2016)
  • Table 11-66: Soluble Systems Corporate Summary
  • Table 11-67: Southwest Technologies Corporate Summary
  • Table 11-68: SteadMed Medical Corporate Summary
  • Table 11-69: Stryker Corp Corporate Summary
  • Table 11-70: Stryker Corp Revenue (2013-2016)
Back to Top